TIGIT Blockade and IL15 in Tumor Immunotherapy: Together is Better
Sign Up to like & getrecommendations! Published in 2020 at "Clinical Cancer Research"
DOI: 10.1158/1078-0432.ccr-20-2538
Abstract: IL15 and TIGIT blockade enhances the natural killer (NK) cell–mediated activity against MHC-I–deficient melanoma both in vitro and in preclinical models. IL15-induced harnessing of NK cells, associated with their unleashing by TIGIT blockade, may represent… read more here.
Keywords: tumor immunotherapy; blockade il15; tigit; tigit blockade ... See more keywords